When Colonization Is Not the Culprit: Multidrug-Resistant Gram-Negative Urinary Tract Infections as a Marker of Risk After Kidney Transplantation [0.03%]
肾脏移植术后多重耐药革兰阴性尿路感染的风险标志而非定植所致
Eric Altneu,Jacqueline Burnell,Aaron Mishkin
Eric Altneu
Victor Kovac,Sarah P Hammond
Victor Kovac
A DOOR to Defining New Outcomes for Research in Transplant Recipients' Infections [0.03%]
受者感染的新型研究结果定义之路
Francesco Cogliati Dezza,Jesús Rodríguez-Baño
Francesco Cogliati Dezza
The Diagnostic Approach to Pulmonary Complications in Allogeneic Hematopoietic Cell Transplantation: To Biopsy or Not? [0.03%]
造血干细胞移植后肺部并发症的诊断方法：活检与否？
Shio Yen Tio,Michelle K Yong,Leon J Worth
Shio Yen Tio
Mpox in Solid Organ Transplant Recipients: Lessons from a Single-Center Case Series in South Florida [0.03%]
南佛罗里达单中心马尔堡移植受者的猴痘病例系列研究中的经验教训
Lubna Osman-Kardash,Elsa Acevedo,Sudiksha Sethia et al.
Lubna Osman-Kardash et al.
Preventing Cat-Astrophe: Toxoplasma Seroprevalence and Prophylaxis Adherence After Allogeneic Stem Cell Transplant [0.03%]
预防猫灾：allo移植后的弓形体感染血清阳性率及预防措施依从性分析
Manogna Metlapalli,Abby P Douglas,Karen Urbancic et al.
Manogna Metlapalli et al.
Infectious Risk Donor Status in Uncontrolled Donation After Circulatory Death and Liver Transplantation [0.03%]
控环状死亡供肝移植中的传染性风险供者状态
Chiara Lazzeri,Paolo Antonio Grossi,Manuela Bonizzoli et al.
Chiara Lazzeri et al.
Backgrounds: Few data are so far available concerning the infectious risk donor profile in uncontrolled donation after circulatory death (uDCDs), despite the high incidence of infectious complications observed in out-of-h...
Invalid Nucleic Acid Test Results May Limit Deceased Donor Organ Utilization [0.03%]
不合法的核酸检测结果可能限制了尸体器官的使用率
Sara Dionne,Hillary Akana,Kaitlin Logue et al.
Sara Dionne et al.
Background: Nucleic acid testing (NAT) is essential for detecting transmissible viral infections in deceased organ donors and guiding safe organ allocation. However, invalid discriminatory NAT (dNAT) results may lead to u...
Possible Donor-Derived Tuberculosis in an Orthotopic Heart Transplant Recipient [0.03%]
心脏移植受者可能发生供体来源的结核病
Phani V Akella,Rachel Sigler
Phani V Akella
Intermittent Letermovir Dosing in Cytomegalovirus High-Risk Liver Transplant Recipients May Facilitate Development of Cell-Mediated Immunity and Prevent Post-Prophylaxis Infection [0.03%]
间断给药Letermovir可能有助于器官移植患者在停用预防性抗病毒药物后诱导细胞介导的免疫反应并防止巨细胞病毒感染复发
Hanna L Kleiboeker,Chris M Saddler,Margaret R Jorgenson
Hanna L Kleiboeker